UPDATE: Deutsche Bank Raises Target to $56 on Nu Skin
Deutsche Bank remains Buy-rated on Nu Skin (NYSE: NUS) on continued success and margin leverage driven buy innovation. It also raises the price target on shares to $56 from $52.
Deutsche Bank says, "Sales and distributor growth momentum, the key to success for any direct seller, persists at Nu Skin, and there are few signs of slowdown with seemingly conservative guidance allowing the recent beat and raise pace to continue. To be sure, valuation is less interesting here and expectations have grown and we don't want to wear out our welcome, but there don't seem to be any looming trouble spots. "
NUS closed at $51.82 a share yesterday.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.